SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1fiz'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1AQ7_B_AG2B4_1 (TRYPSIN AERUGINOSIN 98-B)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	6 / 8	HIS A 57 ASP A 189 GLN A 192 SER A 195 GLY A 216 GLY A 226	None PBZ A 308 (-2.9A) PBZ A 308 (-3.6A) PBZ A 308 (-3.2A) PBZ A 308 (-3.6A) PBZ A 308 ( 3.7A)	0.68A	1aq7A-1fizA: 33.8	1aq7A-1fizA: 37.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1BCU_H_PRLH280_0 (ALPHA-THROMBIN)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	5 / 9	ASP A 189 SER A 195 TRP A 215 GLY A 216 GLY A 226	PBZ A 308 (-2.9A) PBZ A 308 (-3.2A) None PBZ A 308 (-3.6A) PBZ A 308 ( 3.7A)	0.52A	1bcuH-1fizA: 17.5	1bcuH-1fizA: 35.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DF7_A_MTXA501_2 (DIHYDROFOLATE REDUCTASE)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	3 / 3	TRP A 232 ARG A 201 THR A 231	None	1.01A	1df7A-1fizA: undetectable	1df7A-1fizA: 22.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1DWC_H_MITH1_1 (ALPHA-THROMBIN (LARGE SUBUNIT))	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	5 / 9	HIS A 57 ASP A 189 SER A 195 TRP A 215 GLY A 226	None PBZ A 308 (-2.9A) PBZ A 308 (-3.2A) None PBZ A 308 ( 3.7A)	0.41A	1dwcH-1fizA: 34.3	1dwcH-1fizA: 35.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1ETR_H_MITH1_1 (EPSILON-THROMBIN)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	6 / 12	HIS A 57 ASP A 189 SER A 195 TRP A 215 GLY A 216 GLY A 226	None PBZ A 308 (-2.9A) PBZ A 308 (-3.2A) None PBZ A 308 (-3.6A) PBZ A 308 ( 3.7A)	0.54A	1etrH-1fizA: 34.1	1etrH-1fizA: 35.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1F5L_A_AMRA301_1 (UROKINASE-TYPE PLASMINOGEN ACTIVATOR)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	4 / 8	ASP A 189 SER A 195 GLY A 216 GLY A 226	PBZ A 308 (-2.9A) PBZ A 308 (-3.2A) PBZ A 308 (-3.6A) PBZ A 308 ( 3.7A)	0.43A	1f5lA-1fizA: 36.3	1f5lA-1fizA: 32.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1LIN_A_TFPA154_1 (CALMODULIN)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	4 / 7	GLU A 157 LEU A 155 MET A 30 MET A 200	None	1.08A	1linA-1fizA: undetectable	1linA-1fizA: 17.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1TNL_A_TPAA900_1 (TRYPSIN)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	4 / 6	ASP A 189 SER A 195 GLY A 216 GLY A 226	PBZ A 308 (-2.9A) PBZ A 308 (-3.2A) PBZ A 308 (-3.6A) PBZ A 308 ( 3.7A)	0.32A	1tnlA-1fizA: 17.0	1tnlA-1fizA: 37.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1X7P_B_SAMB302_0 (RRNA METHYLTRANSFERASE)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	5 / 10	THR A 190 GLY A 140 GLY A 142 ILE A 188 ALA A 158	PBZ A 308 (-3.4A) None None None None	1.02A	1x7pA-1fizA: undetectable 1x7pB-1fizA: undetectable	1x7pA-1fizA: 19.47 1x7pB-1fizA: 19.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2OTV_A_NCAA1301_0 (CATIONIC TRYPSIN)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	4 / 6	ASP A 189 SER A 195 GLY A 216 GLY A 226	PBZ A 308 (-2.9A) PBZ A 308 (-3.2A) PBZ A 308 (-3.6A) PBZ A 308 ( 3.7A)	0.36A	2otvA-1fizA: 17.1	2otvA-1fizA: 37.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OXT_D_SAMD300_0 (NUCLEOSIDE-2'-O-METH YLTRANSFERASE)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	6 / 12	GLY A 142 GLY A 44 GLY A 196 GLY A 193 THR A 54 LEU A 53	None	1.40A	2oxtD-1fizA: undetectable	2oxtD-1fizA: 19.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2P16_A_GG2A298_1 (COAGULATION FACTOR X (EC 3.4.21.6) (STUART FACTOR) (STUART-PROWER FACTOR))	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	6 / 12	ASP A 189 SER A 195 TRP A 215 GLY A 216 GLY A 226 TYR A 228	PBZ A 308 (-2.9A) PBZ A 308 (-3.2A) None PBZ A 308 (-3.6A) PBZ A 308 ( 3.7A) None	0.41A	2p16A-1fizA: 34.1	2p16A-1fizA: 34.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VIN_A_505A1247_1 (UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	4 / 8	ASP A 189 SER A 195 GLY A 216 GLY A 226	PBZ A 308 (-2.9A) PBZ A 308 (-3.2A) PBZ A 308 (-3.6A) PBZ A 308 ( 3.7A)	0.33A	2vinA-1fizA: 14.1	2vinA-1fizA: 32.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2W26_A_RIVA1001_1 (ACTIVATED FACTOR XA HEAVY CHAIN)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	7 / 12	ASP A 189 SER A 195 TRP A 215 GLY A 216 GLY A 219 GLY A 226 TYR A 228	PBZ A 308 (-2.9A) PBZ A 308 (-3.2A) None PBZ A 308 (-3.6A) None PBZ A 308 ( 3.7A) None	0.50A	2w26A-1fizA: 16.2	2w26A-1fizA: 34.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2YQZ_A_SAMA301_0 (HYPOTHETICAL PROTEIN TTHA0223)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	5 / 12	ILE A 106 ALA A 239 ALA A 246 VAL A 52 LEU A 123	None	0.94A	2yqzA-1fizA: undetectable	2yqzA-1fizA: 20.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BOG_C_DVAC59_0 (6.5 KDA GLYCINE-RICH ANTIFREEZE PROTEIN)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	3 / 3	GLY A 197 GLY A 193 GLY A 43	None	0.37A	3bogC-1fizA: undetectable	3bogC-1fizA: 18.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DCM_X_SAMX5452_0 (UNCHARACTERIZED PROTEIN TM_1570)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	5 / 11	THR A 190 GLY A 140 GLY A 142 ILE A 188 ALA A 158	PBZ A 308 (-3.4A) None None None None	0.97A	3dcmX-1fizA: undetectable	3dcmX-1fizA: 21.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GY3_A_PNTA246_0 (CATIONIC TRYPSIN)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	7 / 11	HIS A 57 ASP A 189 GLN A 192 SER A 195 TRP A 215 GLY A 216 GLY A 226	None PBZ A 308 (-2.9A) PBZ A 308 (-3.6A) PBZ A 308 (-3.2A) None PBZ A 308 (-3.6A) PBZ A 308 ( 3.7A)	0.56A	3gy3A-1fizA: 16.9	3gy3A-1fizA: 37.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IA4_B_MTXB164_2 (DIHYDROFOLATE REDUCTASE)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	4 / 4	PHE A 59 LYS A 61 ILE A 106 THR A 41	None	1.50A	3ia4B-1fizA: undetectable	3ia4B-1fizA: 21.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	4 / 6	SER A 195 TRP A 215 GLY A 216 GLY A 226	PBZ A 308 (-3.2A) None PBZ A 308 (-3.6A) PBZ A 308 ( 3.7A)	0.28A	3rxfA-1fizA: 16.5	3rxfA-1fizA: 37.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SP9_A_IL2A901_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR DELTA)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	5 / 12	THR A 231 HIS A 91 ILE A 103 LEU A 47 VAL A 250	None	1.28A	3sp9A-1fizA: undetectable	3sp9A-1fizA: 23.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SP9_B_IL2B901_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR DELTA)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	5 / 12	THR A 231 HIS A 91 ILE A 103 LEU A 47 VAL A 250	None	1.26A	3sp9B-1fizA: undetectable	3sp9B-1fizA: 23.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ASD_A_BAXA1500_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	4 / 6	ILE A 118 VAL A 31 LEU A 33 ILE A 65	None	0.83A	4asdA-1fizA: undetectable	4asdA-1fizA: 21.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FAK_A_SAMA201_0 (RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE H)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	5 / 10	LEU A 53 ILE A 106 ILE A 212 GLY A 196 GLY A 43	None	1.02A	4fakA-1fizA: undetectable	4fakA-1fizA: 20.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FAK_A_SAMA201_0 (RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE H)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	5 / 10	LEU A 53 ILE A 106 ILE A 212 GLY A 197 GLY A 43	None	0.94A	4fakA-1fizA: undetectable	4fakA-1fizA: 20.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FGZ_A_CQAA301_0 (PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	4 / 8	GLY A 193 GLY A 140 LEU A 155 VAL A 73	None	0.84A	4fgzA-1fizA: undetectable	4fgzA-1fizA: 18.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4FU8_A_ACTA302_0 (UROKINASE-TYPE PLASMINOGEN ACTIVATOR)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	4 / 5	HIS A 57 GLN A 192 GLY A 193 SER A 195	None PBZ A 308 (-3.6A) None PBZ A 308 (-3.2A)	0.87A	4fu8A-1fizA: 36.4	4fu8A-1fizA: 32.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LRH_B_FOLB301_1 (FOLATE RECEPTOR ALPHA)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	3 / 3	ASP A 102 TRP A 63 SER A 195	None None PBZ A 308 (-3.2A)	1.07A	4lrhB-1fizA: undetectable	4lrhB-1fizA: 23.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4M2V_A_BZ1A302_2 (CARBONIC ANHYDRASE 2)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	3 / 3	HIS A 40 VAL A 85 LEU A 65	None	0.71A	4m2vA-1fizA: 0.0	4m2vA-1fizA: 21.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RDX_A_HISA502_0 (HISTIDINE--TRNA LIGASE)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	4 / 7	THR A 190 GLY A 216 TYR A 228 GLY A 226	PBZ A 308 (-3.4A) PBZ A 308 (-3.6A) None PBZ A 308 ( 3.7A)	0.91A	4rdxA-1fizA: undetectable	4rdxA-1fizA: 20.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YDQ_B_HFGB802_0 (PROLINE--TRNA LIGASE)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	5 / 12	PHE A 203 VAL A 209 PRO A 198 THR A 139 GLY A 19	None	1.17A	4ydqB-1fizA: undetectable	4ydqB-1fizA: 19.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5FSA_A_X2NA590_2 (CYP51 VARIANT1)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	3 / 3	PRO A 233 ILE A 106 SER A 178	None	0.68A	5fsaA-1fizA: 0.0	5fsaA-1fizA: 19.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MUE_A_VIVA302_0 (ALPHA-TOCOPHEROL TRANSFER PROTEIN)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	5 / 12	ILE A 108 VAL A 31 ILE A 103 VAL A 209 LEU A 123	None	0.87A	5mueA-1fizA: undetectable	5mueA-1fizA: 20.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MUG_A_VIVA301_0 (ALPHA-TOCOPHEROL TRANSFER PROTEIN)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	5 / 12	ILE A 108 VAL A 31 ILE A 103 VAL A 209 LEU A 123	None	0.89A	5mugA-1fizA: undetectable	5mugA-1fizA: 20.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TWJ_D_SAMD201_0 (RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE H)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	6 / 11	LEU A 53 ILE A 45 GLY A 44 GLY A 43 SER A 230 VAL A 209	None	1.40A	5twjD-1fizA: undetectable	5twjD-1fizA: 21.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Y9Y_A_ACTA409_0 (UNCHARACTERIZED PROTEIN KDOO)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	3 / 3	LYS A 75 PRO A 75 LYS A 77	None	0.92A	5y9yA-1fizA: 0.0	5y9yA-1fizA: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6C2M_C_SUEC1203_0 (NS3 PROTEASE)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	5 / 12	HIS A 57 ASP A 102 GLY A 193 SER A 195 VAL A 217	None None None PBZ A 308 (-3.2A) None	0.88A	6c2mC-1fizA: 9.5	6c2mC-1fizA: 16.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HU9_H_PCFH604_0 (CYTOCHROME B-C1 COMPLEX SUBUNIT 8 CYTOCHROME C OXIDASE POLYPEPTIDE 5A, MITOCHONDRIAL)	1fiz	BETA-ACROSIN HEAVY CHAIN (Sus scrofa)	4 / 8	GLY A 216 GLY A 193 SER A 195 ALA A 55	PBZ A 308 (-3.6A) None PBZ A 308 (-3.2A) None	0.78A	6hu9H-1fizA: undetectable 6hu9e-1fizA: undetectable	6hu9H-1fizA: 12.98 6hu9e-1fizA: 19.77

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1AQ7_B_AG2B4_1","TRYPSIN;AERUGINOSIN 98-B","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",6,"HIS A  57;ASP A 189;GLN A 192;SER A 195;GLY A 216;GLY A 226","None;PBZ A 308 (-2.9A);PBZ A 308 (-3.6A);PBZ A 308 (-3.2A);PBZ A 308 (-3.6A);PBZ A 308 ( 3.7A)","0.68A","1aq7A-1fizA:33.8","1aq7A-1fizA:37.70"],["1BCU_H_PRLH280_0","ALPHA-THROMBIN","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",5,"ASP A 189;SER A 195;TRP A 215;GLY A 216;GLY A 226","PBZ A 308 (-2.9A);PBZ A 308 (-3.2A);None;PBZ A 308 (-3.6A);PBZ A 308 ( 3.7A)","0.52A","1bcuH-1fizA:17.5","1bcuH-1fizA:35.00"],["1DF7_A_MTXA501_2","DIHYDROFOLATE REDUCTASE","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",3,"TRP A 232;ARG A 201;THR A 231","None","1.01A","1df7A-1fizA:undetectable","1df7A-1fizA:22.62"],["1DWC_H_MITH1_1","ALPHA-THROMBIN (LARGE SUBUNIT)","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",5,"HIS A  57;ASP A 189;SER A 195;TRP A 215;GLY A 226","None;PBZ A 308 (-2.9A);PBZ A 308 (-3.2A);None;PBZ A 308 ( 3.7A)","0.41A","1dwcH-1fizA:34.3","1dwcH-1fizA:35.00"],["1ETR_H_MITH1_1","EPSILON-THROMBIN","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",6,"HIS A  57;ASP A 189;SER A 195;TRP A 215;GLY A 216;GLY A 226","None;PBZ A 308 (-2.9A);PBZ A 308 (-3.2A);None;PBZ A 308 (-3.6A);PBZ A 308 ( 3.7A)","0.54A","1etrH-1fizA:34.1","1etrH-1fizA:35.46"],["1F5L_A_AMRA301_1","UROKINASE-TYPE PLASMINOGEN ACTIVATOR","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",4,"ASP A 189;SER A 195;GLY A 216;GLY A 226","PBZ A 308 (-2.9A);PBZ A 308 (-3.2A);PBZ A 308 (-3.6A);PBZ A 308 ( 3.7A)","0.43A","1f5lA-1fizA:36.3","1f5lA-1fizA:32.71"],["1LIN_A_TFPA154_1","CALMODULIN","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",4,"GLU A 157;LEU A 155;MET A  30;MET A 200","None","1.08A","1linA-1fizA:undetectable","1linA-1fizA:17.87"],["1TNL_A_TPAA900_1","TRYPSIN","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",4,"ASP A 189;SER A 195;GLY A 216;GLY A 226","PBZ A 308 (-2.9A);PBZ A 308 (-3.2A);PBZ A 308 (-3.6A);PBZ A 308 ( 3.7A)","0.32A","1tnlA-1fizA:17.0","1tnlA-1fizA:37.21"],["1X7P_B_SAMB302_0","RRNA METHYLTRANSFERASE","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",5,"THR A 190;GLY A 140;GLY A 142;ILE A 188;ALA A 158","PBZ A 308 (-3.4A);None;None;None;None","1.02A","1x7pA-1fizA:undetectable;1x7pB-1fizA:undetectable","1x7pA-1fizA:19.47;1x7pB-1fizA:19.47"],["2OTV_A_NCAA1301_0","CATIONIC TRYPSIN","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",4,"ASP A 189;SER A 195;GLY A 216;GLY A 226","PBZ A 308 (-2.9A);PBZ A 308 (-3.2A);PBZ A 308 (-3.6A);PBZ A 308 ( 3.7A)","0.36A","2otvA-1fizA:17.1","2otvA-1fizA:37.70"],["2OXT_D_SAMD300_0","NUCLEOSIDE-2'-O-METHYLTRANSFERASE","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",6,"GLY A 142;GLY A  44;GLY A 196;GLY A 193;THR A  54;LEU A  53","None","1.40A","2oxtD-1fizA:undetectable","2oxtD-1fizA:19.72"],["2P16_A_GG2A298_1","COAGULATION FACTOR X (EC 3.4.21.6) (STUART FACTOR) (STUART-PROWER FACTOR)","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",6,"ASP A 189;SER A 195;TRP A 215;GLY A 216;GLY A 226;TYR A 228","PBZ A 308 (-2.9A);PBZ A 308 (-3.2A);None;PBZ A 308 (-3.6A);PBZ A 308 ( 3.7A);None","0.41A","2p16A-1fizA:34.1","2p16A-1fizA:34.34"],["2VIN_A_505A1247_1","UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",4,"ASP A 189;SER A 195;GLY A 216;GLY A 226","PBZ A 308 (-2.9A);PBZ A 308 (-3.2A);PBZ A 308 (-3.6A);PBZ A 308 ( 3.7A)","0.33A","2vinA-1fizA:14.1","2vinA-1fizA:32.71"],["2W26_A_RIVA1001_1","ACTIVATED FACTOR XA HEAVY CHAIN","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",7,"ASP A 189;SER A 195;TRP A 215;GLY A 216;GLY A 219;GLY A 226;TYR A 228","PBZ A 308 (-2.9A);PBZ A 308 (-3.2A);None;PBZ A 308 (-3.6A);None;PBZ A 308 ( 3.7A);None","0.50A","2w26A-1fizA:16.2","2w26A-1fizA:34.34"],["2YQZ_A_SAMA301_0","HYPOTHETICAL PROTEIN TTHA0223","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",5,"ILE A 106;ALA A 239;ALA A 246;VAL A  52;LEU A 123","None","0.94A","2yqzA-1fizA:undetectable","2yqzA-1fizA:20.49"],["3BOG_C_DVAC59_0","6.5 KDA GLYCINE-RICH ANTIFREEZE PROTEIN","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",3,"GLY A 197;GLY A 193;GLY A  43","None","0.37A","3bogC-1fizA:undetectable","3bogC-1fizA:18.01"],["3DCM_X_SAMX5452_0","UNCHARACTERIZED PROTEIN TM_1570","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",5,"THR A 190;GLY A 140;GLY A 142;ILE A 188;ALA A 158","PBZ A 308 (-3.4A);None;None;None;None","0.97A","3dcmX-1fizA:undetectable","3dcmX-1fizA:21.76"],["3GY3_A_PNTA246_0","CATIONIC TRYPSIN","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",7,"HIS A  57;ASP A 189;GLN A 192;SER A 195;TRP A 215;GLY A 216;GLY A 226","None;PBZ A 308 (-2.9A);PBZ A 308 (-3.6A);PBZ A 308 (-3.2A);None;PBZ A 308 (-3.6A);PBZ A 308 ( 3.7A)","0.56A","3gy3A-1fizA:16.9","3gy3A-1fizA:37.70"],["3IA4_B_MTXB164_2","DIHYDROFOLATE REDUCTASE","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",4,"PHE A  59;LYS A  61;ILE A 106;THR A  41","None","1.50A","3ia4B-1fizA:undetectable","3ia4B-1fizA:21.67"],["3RXF_A_4APA9_1","CATIONIC TRYPSIN","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",4,"SER A 195;TRP A 215;GLY A 216;GLY A 226","PBZ A 308 (-3.2A);None;PBZ A 308 (-3.6A);PBZ A 308 ( 3.7A)","0.28A","3rxfA-1fizA:16.5","3rxfA-1fizA:37.70"],["3SP9_A_IL2A901_1","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",5,"THR A 231;HIS A  91;ILE A 103;LEU A  47;VAL A 250","None","1.28A","3sp9A-1fizA:undetectable","3sp9A-1fizA:23.20"],["3SP9_B_IL2B901_1","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",5,"THR A 231;HIS A  91;ILE A 103;LEU A  47;VAL A 250","None","1.26A","3sp9B-1fizA:undetectable","3sp9B-1fizA:23.20"],["4ASD_A_BAXA1500_2","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",4,"ILE A 118;VAL A  31;LEU A  33;ILE A  65","None","0.83A","4asdA-1fizA:undetectable","4asdA-1fizA:21.69"],["4FAK_A_SAMA201_0","RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE H","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",5,"LEU A  53;ILE A 106;ILE A 212;GLY A 196;GLY A  43","None","1.02A","4fakA-1fizA:undetectable","4fakA-1fizA:20.22"],["4FAK_A_SAMA201_0","RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE H","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",5,"LEU A  53;ILE A 106;ILE A 212;GLY A 197;GLY A  43","None","0.94A","4fakA-1fizA:undetectable","4fakA-1fizA:20.22"],["4FGZ_A_CQAA301_0","PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",4,"GLY A 193;GLY A 140;LEU A 155;VAL A  73","None","0.84A","4fgzA-1fizA:undetectable","4fgzA-1fizA:18.06"],["4FU8_A_ACTA302_0","UROKINASE-TYPE PLASMINOGEN ACTIVATOR","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",4,"HIS A  57;GLN A 192;GLY A 193;SER A 195","None;PBZ A 308 (-3.6A);None;PBZ A 308 (-3.2A)","0.87A","4fu8A-1fizA:36.4","4fu8A-1fizA:32.10"],["4LRH_B_FOLB301_1","FOLATE RECEPTOR ALPHA","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",3,"ASP A 102;TRP A  63;SER A 195","None;None;PBZ A 308 (-3.2A)","1.07A","4lrhB-1fizA:undetectable","4lrhB-1fizA:23.08"],["4M2V_A_BZ1A302_2","CARBONIC ANHYDRASE 2","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",3,"HIS A  40;VAL A  85;LEU A  65","None","0.71A","4m2vA-1fizA:0.0","4m2vA-1fizA:21.59"],["4RDX_A_HISA502_0","HISTIDINE--TRNA LIGASE","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",4,"THR A 190;GLY A 216;TYR A 228;GLY A 226","PBZ A 308 (-3.4A);PBZ A 308 (-3.6A);None;PBZ A 308 ( 3.7A)","0.91A","4rdxA-1fizA:undetectable","4rdxA-1fizA:20.31"],["4YDQ_B_HFGB802_0","PROLINE--TRNA LIGASE","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",5,"PHE A 203;VAL A 209;PRO A 198;THR A 139;GLY A  19","None","1.17A","4ydqB-1fizA:undetectable","4ydqB-1fizA:19.24"],["5FSA_A_X2NA590_2","CYP51 VARIANT1","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",3,"PRO A 233;ILE A 106;SER A 178","None","0.68A","5fsaA-1fizA:0.0","5fsaA-1fizA:19.83"],["5MUE_A_VIVA302_0","ALPHA-TOCOPHEROL TRANSFER PROTEIN","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",5,"ILE A 108;VAL A  31;ILE A 103;VAL A 209;LEU A 123","None","0.87A","5mueA-1fizA:undetectable","5mueA-1fizA:20.50"],["5MUG_A_VIVA301_0","ALPHA-TOCOPHEROL TRANSFER PROTEIN","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",5,"ILE A 108;VAL A  31;ILE A 103;VAL A 209;LEU A 123","None","0.89A","5mugA-1fizA:undetectable","5mugA-1fizA:20.64"],["5TWJ_D_SAMD201_0","RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE H","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",6,"LEU A  53;ILE A  45;GLY A  44;GLY A  43;SER A 230;VAL A 209","None","1.40A","5twjD-1fizA:undetectable","5twjD-1fizA:21.92"],["5Y9Y_A_ACTA409_0","UNCHARACTERIZED PROTEIN KDOO","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",3,"LYS A  75;PRO A  75;LYS A  77","None","0.92A","5y9yA-1fizA:0.0","5y9yA-1fizA:20.00"],["6C2M_C_SUEC1203_0","NS3 PROTEASE","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",5,"HIS A  57;ASP A 102;GLY A 193;SER A 195;VAL A 217","None;None;None;PBZ A 308 (-3.2A);None","0.88A","6c2mC-1fizA:9.5","6c2mC-1fizA:16.47"],["6HU9_H_PCFH604_0","CYTOCHROME B-C1 COMPLEX SUBUNIT 8;CYTOCHROME C OXIDASE POLYPEPTIDE 5A, MITOCHONDRIAL","1fiz","BETA-ACROSIN HEAVY CHAIN","Sus scrofa",4,"GLY A 216;GLY A 193;SER A 195;ALA A  55","PBZ A 308 (-3.6A);None;PBZ A 308 (-3.2A);None","0.78A","6hu9H-1fizA:undetectable;6hu9e-1fizA:undetectable","6hu9H-1fizA:12.98;6hu9e-1fizA:19.77"]]